NCT04724473View on ClinicalTrials.gov

A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne Vulgaris

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

1,030

Participants

Timeline

Start Date

December 10, 2019

Primary Completion Date

November 21, 2020

Study Completion Date

November 21, 2020

Conditions

Acne Vulgaris

Interventions

DRUG

Tretinoin Cream 0.025%

The study medication will be self-applied topically on the affected areas of the face lightly, once daily at bedtime, avoiding contact with the mouth, eyes, and other mucous membranes for 84 consecutive days.

Trial Locations (1)

28217

Catawba Research, LLC, Charlotte

All Listed Sponsors

lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT04724473 - A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter